BullFrog AI Founder and CEO Vin Singh to Deliver Keynote at AIDDD Summit
Key Highlights
- ➤Vin Singh to deliver AIDDD Summit keynote in Boston on October 27, 2026
- ➤Keynote will examine AI drug discovery timelines, costs and clinical progress
- ➤BullFrog AI operates bfPREP, bfLEAP and bfARENAS capabilities
- ➤BullFrog AI emphasizes traceable, human-validated analytical recommendations
Expert Statements
Vin Singh, Founder and Chief Executive Officer of BullFrog AI
“AI Drug Discovery: How Far We've Come”
GAITHERSBURG, Md., Oct. 27, 2026 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI"), an AI company using its proprietary platform to turn complex biomedical data into actionable insights, today announced that Vin Singh, Founder and Chief Executive Officer, will deliver the keynote at the AI Drug Discovery & Development (“AIDDD”) Summit today, October 27, 2026, at 5:30 p.m. Eastern Time in Boston.
The keynote, titled “AI Drug Discovery: How Far We've Come,” will examine the progress of artificial intelligence in drug discovery and development, including accelerated discovery timelines, reduced early-stage costs and the growing number of AI-derived drug candidates entering clinical trials.
Get started
Create a free account to read the full story.